Page last updated: 2024-08-25

5,6-benzocoumarin-3-carboxylic acid ethyl ester and warfarin

5,6-benzocoumarin-3-carboxylic acid ethyl ester has been researched along with warfarin in 1 studies

*Warfarin: An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. [MeSH]

*Warfarin: An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beketova, TP; Korolev, VV; Prokhorov, NI; Rumiantsev, GI1

Other Studies

1 other study(ies) available for 5,6-benzocoumarin-3-carboxylic acid ethyl ester and warfarin

ArticleYear
[Ultrastructural studies of lung and liver tissue of white rats inhaling 3-phenyl-5,6-benzocoumarin and the ethyl ester of 5,6-benzocoumarin-3-carboxylic acid].
    Gigiena i sanitariia, 1981, Issue:7

    Topics: Animals; Anticoagulants; Coumarins; Dose-Response Relationship, Drug; Environmental Exposure; Liver; Lung; Microscopy, Electron; Rats; Time Factors

1981